Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-24 @ 10:00 PM
NCT ID:
NCT05623332
Eligibility Criteria:
Inclusion Criteria:
* Participant is willing and able to give informed consent for participation in the study.
* Female aged 18 years or above.
* Symptoms consistent with endometriosis and therefore due to undergo a laparoscopy for diagnostic (+/- therapeutic) purposes.
* Willing and able to comply with scheduled visits.
* In the Investigator's opinion, is able and willing to comply with all study requirements.
* Women enrolling for the tissue sample comparison group: Women undergoing planned surgery (including hysterectomy) for gynaecological disease except endometriosis e.g., fibroid-associated symptoms such as abdominal pain, abnormal uterine bleeding, fertility investigation or for laparoscopic tubal sterilisation.
Exclusion Criteria:
* Female participant who is pregnant, lactating or planning pregnancy during the study.
* Known significant renal or hepatic impairment (E.g., eGFR \<50ml/min/1.73m2 on recent blood tests).
* Any significant disease or disorder such as gynaecological cancers, in the opinion of the Investigator, may either put the participants at risk because of participation in the study or may influence the result of the study.
* High dose intravenous or intramuscular steroid in the past 12 weeks.
* Participants with a known allergy to technetium.
* Participants who have recently participated in another research study, in the opinion of the investigator will affect the results of the project.
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05623332
Study Brief:
Protocol Section:
NCT05623332